{"id":342,"date":"2017-03-01T10:57:55","date_gmt":"2017-03-01T09:57:55","guid":{"rendered":"http:\/\/neu.velixx.com\/2017\/03\/medtechdialiog_2015\/"},"modified":"2017-03-21T15:26:14","modified_gmt":"2017-03-21T14:26:14","slug":"medtechdialiog_2015","status":"publish","type":"post","link":"https:\/\/www.velixx.com\/en\/2017\/03\/medtechdialiog_2015\/","title":{"rendered":"velixX at MedTechDialog"},"content":{"rendered":"<h2>velixX at MedTechDialog<\/h2>\n<p>The MedTechDialog in the Rhine-Neckar metropolitan region brings together industry experts interested in medical technology to discuss the latest trends and explore special topics.\u00a0The recent MedTechDialog took place on September 9, 2014 in Mannheim, organized by the city of Mannheim and PWC (PricewaterhouseCoopers Aktiengesellschaft Wirtschaftspr\u00fcfungsgesellschaft). A stimulating exchange ensued on the theme of &#8220;recognizing and skillfully accessing public support programs for corporate and product development&#8221;. Attractive opportunities for funding and financing of R&amp;D projects on the state, federal, and EU level were presented and discussed, a highly relevant topic for managers and decision-makers in the metropolitan area.<\/p>\n<p>At the event, Mr. Manfred Augstein (CEO, velixX GmbH) presented the recent successful experience of velixX in acquiring project funding from the Central Innovation Program SME (Zentrales Innovationsprogramm Mittelstand, ZIM) for an upcoming in-house product development project (in cooperation with two other SMEs). The funding (in the range of 430 thousand euros) will be provided over a period of two years.\u00a0Demonstrating with a practical example, Mr. Augstein described the funding process involved and how it offers great advantages for projects that may sometimes be considered risky due to their niche nature. Currently, velixX has two product development projects for which government funding has been approved.<\/p>\n<p>We hope to see you at the next MedTechDialog on December 9, 2014 at Technoseum Mannheim.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-344 size-full\" src=\"https:\/\/www.velixx.com\/wp-content\/uploads\/2017\/03\/pic_pwa.jpg\" alt=\"\" width=\"558\" height=\"281\" srcset=\"https:\/\/www.velixx.com\/wp-content\/uploads\/2017\/03\/pic_pwa.jpg 558w, https:\/\/www.velixx.com\/wp-content\/uploads\/2017\/03\/pic_pwa-300x151.jpg 300w\" sizes=\"(max-width: 558px) 100vw, 558px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>velixX at MedTechDialog The MedTechDialog in the Rhine-Neckar metropolitan region [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":279,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"_links":{"self":[{"href":"https:\/\/www.velixx.com\/en\/wp-json\/wp\/v2\/posts\/342"}],"collection":[{"href":"https:\/\/www.velixx.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.velixx.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.velixx.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.velixx.com\/en\/wp-json\/wp\/v2\/comments?post=342"}],"version-history":[{"count":0,"href":"https:\/\/www.velixx.com\/en\/wp-json\/wp\/v2\/posts\/342\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.velixx.com\/en\/wp-json\/wp\/v2\/media\/279"}],"wp:attachment":[{"href":"https:\/\/www.velixx.com\/en\/wp-json\/wp\/v2\/media?parent=342"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.velixx.com\/en\/wp-json\/wp\/v2\/categories?post=342"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.velixx.com\/en\/wp-json\/wp\/v2\/tags?post=342"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}